DrugWise Discovery ApS: Financial statements 2024
CVR: 43888862
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
DrugWise Discovery ApS (CVR 43888862) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 135,247 and a net result of DKK 104,809 compared with DKK 223,041 the year before. That is a decrease of 52.8% compared with the year before. Equity in the 2024 report amounted to DKK 366,919. The solvency ratio was 65.2%.
- Gross Profit
- DKK 135,247
- Profit/Loss
- DKK 104,809
- Equity
- DKK 366,919
- Total Assets
- DKK 562,733
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
DrugWise Discovery ApS has published its interim report for the period February 16, 2023 to December 31, 2023.
About DrugWise Discovery ApS
DrugWise Discovery ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2023. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Samra Joke Sanni. The company is owned by NSSK Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 266,857 and a net result of DKK 208,161 compared with DKK 104,809 the year before. Equity in the 2025 report amounted to DKK 575,081.